We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Siemens Healthineers Showcases Latest Diagnostic Innovations

By LabMedica International staff writers
Posted on 08 Feb 2017

Image: The Aptio automation solution is designed to enhance lab productivity (Photo courtesy of Siemens Healthineers).

Image: The Aptio automation solution is designed to enhance lab productivity (Photo courtesy of Siemens Healthineers).

Siemens Healthineers demonstrated its latest diagnostic products and solutions at MEDLAB 2017 held in Dubai, UAE, from February 6-9, 2017.

Siemens offers a broad spectrum of immunoassay, chemistry, hematology, molecular, urinalysis, and blood gas testing systems, in conjunction with automation, informatics and services, for meeting the needs of laboratories of all sizes. At MEDLAB 2017, the company displayed its Aptio Automation solutions that advance productivity by allowing laboratories to accelerate sample processing, achieve consistent turnaround times, and proactively control their operations for better patient outcomes. Also on display was its ADVIA Chemistry XPT system, which has been engineered to consistently meet expanding chemistry workloads and enhance patient care, and ADVIA Centaur XPT immunoassay system, which enhances workflow to meet demands for reliable and rapid immunoassay testing.

Siemens also exhibited its ADVIA 2120i Hematology System with Autoslide, the Sysmex CS-5100 and CS-2500 hemostasis systems, the VERSANT kPCR molecular system with MiPLX software solution, and the RAPIDPoint 500 blood gas system. Other products on display at the event by Siemens included the Xprecia Stride coagulation analyzer, DCA Vantage HbA1c analyzer, and its CLINITEK range of urine chemistry analyzers.

Visit expo >

Gold Member

Flocked Fiber Swabs

Puritan® Patented HydraFlock®

New

Gold Member

Nucleic Acid Extractor System

NEOS-96 XT

New

Automated Urinalysis Solution

UN-9000

New

Steam Sterilizer

Hi Vac II Line

Latest MEDLAB 2017 News

Channels

Clinical Chemistry

view channel

Blood Test Predicts Alzheimer Disease Risk Before Imaging Changes and Symptoms

Alzheimer's disease often advances silently for years, making timely risk stratification difficult in routine practice. Current approaches to detect pathology can involve lumbar puncture or positron emission... Read more

Image: ApoB is a blood test that counts the total number of harmful particles in circulation, providing a more complete assessment of risk (photo courtesy of Adobe Stock)

Study Finds ApoB Testing More Effective Than LDL for Guiding Lipid Therapy

Routine blood tests that measure low-density lipoprotein (LDL), commonly known as “bad” cholesterol, are widely used to guide lipid-lowering therapy, but they do not always provide a complete picture of... Read more

Image: Overview of the dual-mode xVFA optical sensor platform for multiplexed cardiac biomarker detection in point-of-care settings (Han, GR., Eryilmaz, M., Goncharov, A. et al. Light Sci Appl 15, 190 (2026). doi.org/10.1038/s41377-026-02275-9)

AI-Enabled POC Test Quantifies Multiple Cardiac Biomarkers

Cardiovascular diseases are a leading cause of death, responsible for nearly 20 million deaths each year. Timely triage of myocardial infarction and heart failure hinges on rapid cardiac biomarker measurement,... Read more

Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing

Clinical laboratories continue to face staffing shortages, limited space, and growing test volumes that pressure chemistry and electrolyte workflows. Maintaining rapid turnaround times increasingly depends... Read more

Molecular Diagnostics

view channel

Image: The STRIPE platform enables deep sequencing of full-length RNA molecules for any customized disease-relevant panel (photo courtesy of Shutterstock)

Long-Read RNA Sequencing Platform Improves Rare Disease Diagnosis

Rare genetic diseases often evade definitive diagnosis even after exome or genome sequencing, leaving many families without clear answers. Standard DNA-based tests can miss variants that disrupt RNA transcription... Read more

Ultrasensitive Assay Reveals Previously Undetected Tuberculosis in Hospital Patients

Tuberculosis remains the leading cause of death from an infectious disease worldwide, and diagnosis can be difficult when bacterial load is low or disease is atypical. In the United States, the disease... Read more

Study Confirms Barrett’s Esophagus as Precursor to Esophageal Cancer

Esophageal adenocarcinoma is rising in Western countries and is often detected late, limiting treatment options. Clinicians suspect many cases begin in Barrett’s esophagus, yet the precursor lesion is... Read more

Urine-Based Assay Predicts Severe Dengue Risk Early

Dengue is among the most widespread mosquito-borne infections, yet early risk stratification can be difficult when symptoms overlap with other febrile illnesses. Only about 2% to 5% of patients develop... Read more

Hematology

view channel

Routine Blood Test Parameters Link Anemia to Cancer Risk and Mortality

Anemia detected in routine care can signal underlying pathology and is frequently encountered in adults. Because it is defined by hemoglobin levels below the normal range, it is often evaluated with red... Read more

Prognostic Tool Guides Personalized Treatment in Rare Blood Cancer

Chronic myelomonocytic leukemia (CMML) is a rare blood cancer in which acquired genetic mutations in bone marrow stem cells drive disease. Stem cell transplantation is the only curative option but carries... Read more

New Platelet Function Assay Enables Monitoring of Antiplatelet Therapy

Monitoring response to antiplatelet therapy remains challenging for many clinical laboratories. Aggregation-based assays and cartridge systems often require specialized personnel, dedicated instruments,... Read more

Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers

Blood cancers encompass diverse entities whose biology and clinical behavior are best understood through integrative analyses across large cohorts. However, multi‑omic datasets and outcomes information... Read more

Immunology

view channel

Study Finds Influenza Often Undiagnosed in Winter Deaths

Seasonal influenza drives substantial excess mortality, yet its contribution is often obscured when infections go undiagnosed near the time of death. Many deaths occur outside hospitals or in older adults... Read more

Combined Screening Approach Identifies Early Leprosy Cases

Leprosy remains a significant public health concern, with more than 200,000 new cases reported globally each year and early disease often escaping routine laboratory detection. In its initial phase, bacterial... Read more

Image: Mycobacterium tuberculosis bacteria seen with a scanning electron microscope (Credit: CDC PHIL)

Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

Active tuberculosis (TB) remains a leading cause of death and illness worldwide, yet distinguishing contagious disease from latent infection continues to challenge clinicians. Standard screening tools... Read more

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more

Microbiology

view channel

Syndromic Panel Enables Rapid Identification of Bloodstream Infections

Bloodstream infections require rapid identification of causative pathogens and resistance determinants to guide therapy, yet laboratories often face pressure to deliver clinically relevant results quickly... Read more

RNA-Based Workflow Identifies Active Skin Microbes for Dermatology Research

Human skin carries diverse microbial communities that influence barrier function and inflammation, yet identifying which organisms are metabolically active has been challenging. DNA-based surveys catalog... Read more

Cost-Effective Sampling and Sequencing Workflow Identifies ICU Infection Hotspots

Intensive care units face persistent threats from hospital-acquired infections, increasingly driven by drug-resistant bacteria. Rapidly pinpointing environmental reservoirs and transmission hotspots remains... Read more

New Bacterial Target Identified for Early Detection of Noma

Noma is a rapidly progressing orofacial infection that begins as gingivitis and can destroy oral and facial tissues, primarily affecting young children living in extreme poverty. Without treatment, it... Read more

Pathology

view channel

Biomarker Predicts Immunotherapy Response and Prognosis in Colorectal Cancer

Colorectal cancer is common and often lethal, and therapeutic decision-making is complicated by heterogeneous tumor microenvironments. Immunotherapy benefits only a small subset of patients, around 5%,... Read more

Collaboration Applies AI Pathology to Predict Response to Antibody-Drug Conjugates

Antibody-drug conjugates (ADC) are reshaping oncology, yet scalable biomarkers that reliably predict which patients will benefit remain limited as treatment regimens and combinations grow more complex.... Read more

AI Improves Completeness of Complex Cancer Pathology Reports

Oncology teams increasingly rely on pathology reports that integrate histopathology, immunohistochemistry, and rapidly expanding biomarker testing. As patients live longer and undergo repeated analyses... Read more

AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

Small cell lung cancer often presents at an extensive stage and progresses rapidly, leaving little time to tailor first-line therapy. Clinicians currently lack biomarkers to guide which patients will benefit... Read more

Technology

view channel

AI Tool Predicts Non-Response to Targeted Therapy in Colorectal Cancer

Advanced bowel cancer remains difficult to treat, and many patients receive targeted therapies that do not help them but still cause harm. Clinicians need reliable ways to identify likely responders before... Read more

Integrated System Streamlines Pre-Analytical Workflow for Molecular Testing

Pre-analytical variation remains a leading source of inconsistent molecular test results and added costs, particularly when laboratories rely on multiple instruments and protocols. Standardizing nucleic... Read more

Noninvasive Sputum Test Detects Early Lung Cancer

Early detection remains critical for improving outcomes in lung cancer, yet clinicians increasingly encounter indeterminate pulmonary nodules found incidentally or through screening, complicating decision-making.... Read more

Image: Graphical Abstract (Huiqian Hu et al., Med 7(3): 100966 (2026). DOI: 10.1016/j.medj.2025.100966)

New AI Tool Enables Rapid Treatment Selection in Pediatric Leukemia

Children with T-cell acute lymphoblastic leukemia face an aggressive disease that remains difficult to treat. Although remission rates have improved, many survivors experience long-term effects from intensive... Read more

Industry

view channel

Beckman Coulter Gains CE Mark for Rapid Assay Distinguishing Bacterial vs Viral Infections

Clinicians often struggle to distinguish bacterial from viral infections at first presentation because symptoms overlap and definitive culture or molecular results can take hours or days.... Read more

Junction, GRAIL Enable Scalable Access to Multi-Cancer Detection Test

Junction has announced a collaboration with GRAIL to enable broad access to the Galleri multi-cancer early detection (MCED) blood test across digital health platforms and clinical organizations.... Read more

GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR

GRAIL’s Galleri multi-cancer early detection (MCED) test is being integrated into Epic’s electronic health record (EHR) platform through Epic Aura. The collaboration is designed to let clinicians at interested... Read more

Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials

CellCarta and Pillar Biosciences announced a global, multi-year strategic partnership on April 2, 2026 to broaden access to operationally streamlined next-generation sequencing (NGS) tumor profiling for... Read more